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Abstract
Background:  Intracellular trafficking of mycobacteria is comprehensively dependent on the
unusual regulation of host proteins. Recently, we have reported that infection of macrophages by
Mycobacterium tuberculosis H37Rv (Rv) selectively downregulates the expression of PKCα while
infection by Mycobacterium smegmatis (MS) does not.
Results: Based on our earlier study, we have extrapolated for the first time that knockdown of
PKCα, impairs phagocytosis of mycobacteria by macrophages while their intracellular survival is
drastically increased. Mycobacterium bovis BCG (BCG) and Mycobacterium tuberculosis H37Ra (Ra)
have also been shown to downregulate the expression of PKCα during the infection. Since PknG
is uniquely expressed in BCG, Ra, Rv but not in MS and has been reported to promote intracellular
survival of mycobacteria, led us to believe that PknG may be involved in such downregulation of
PKCα. THP-1 cells infected with recombinant MS expressing PknG (MS-G), showed significant
reduction in PKCα expression. In normal THP-1 cells survival of MS-G was enhanced as compared
to MS, while their behavior in PKCα deficient cells could not be distinguished. The results strongly
demonstrate that pathogenic mycobacteria recognize and then inhibit PKCα to circumvent
phagocytosis and the hostile environment of macrophages. We emphasize that, this inhibition is
controlled by PknG.
Conclusions: All together, our data reveal a mechanism that shows substantial interdependence
of PKCα with PknG, in sustaining mycobacterial infection.
Background
Mycobacterium tuberculosis (Mtb), the causative agent of
tuberculosis, has infected billions of people worldwide.
Phagocytic cells are critical for host defense against infec-
tion by capturing invading pathogens and killing them
inside the bactericidal milieu of lysosomes as well as in
processing and presenting the pathogen derived antigens.
Based on the ability to infect and cause diseases, mycobac-
teria can be classified into species that cause TB in humans
or in animals, including Mtb and M. bovis, and species that
are generally non-pathogenic, such as MS and M. vaccae.
The survival of pathogenic mycobacteria within macro-
phages involves the inhibition of several host cell proc-
esses which allow them unlike non-pathogenic species to
survive inside host cells. Host processes manipulated by
pathogenic mycobacteria include fusion of phagosomes
with lysosomes, acidification of phagosomes and resist-
ance to killing by oxygenated metabolites. Antigen pres-
entation, apoptosis and the stimulation of bactericidal
responses due to the activation of pathways involving
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mitogen-activated protein kinases (MAPKs), interferon-γ
(IFN-γ) and calcium (Ca2+) signaling are also inhibited.
The phagocytosis of pathogen is associated with an
increase in cellular Ca2+ and subsequent activation of Ca2+
dependent events leading to destruction of invading
bacilli [1]. Pathogenic mycobacteria inhibit the Ca2+ flux
which is usually associated with phagocytosis [2,3]. Ca2+
is required for the activation of certain isoforms of PKC
and the calmodulin kinase pathways, which are both
potential upstream activators of MAP kinases [4].
Modulation of host cellular pathways may be influenced
by signal transduction molecules expressed by pathogenic
bacteria. The Mtb genome encodes 11 eukaryotic-like ser-
ine/threonine kinases [5,6]. Various signal-transduction
pathways utilize protein phosphorylation/dephosphor-
ylation in regulating different cellular activities such as
adaptation and differentiation, immune response and cell
division. Several studies have shown that macrophages
infected with pathogenic mycobacteria show reduced acti-
vation of MAP kinases as compared with non-pathogenic
mycobacteria resulting in the decreased production of
NOS2 and TNF-α in infected macrophages [7,8].
Recent studies have highlighted the role of protein kinases
in the biology and pathogenesis of mycobacteria. PknG, a
cytosolic protein of Mtb, increases intracellular survival by
inhibiting the fusion of mycobacterial phagosome with
lysosome. Deletion of this gene in BCG results in the lys-
osomal localization of mycobacteria. Likewise MS
expressing recombinant PknG is able to prevent the fusion
of phagosome with lysosome [9]. The members of the
PKC-family of proteins are classified in three groups,
based on the mechanisms regulating their activation in
response to different stimuli [10,11]. PKC has been impli-
cated in various macrophage functions like phagocytosis,
maturation of phagosome, immunity to infection, apop-
tosis and the productions of cytokines/chemokines/
immune effector molecules [10,12-14]. PKC-α regulates
phagocytosis and the biogenesis of phagolysosome by
promoting the interaction of phagosome with late
endososme and lysosomes [13,15-17]. PKC-α also plays
important role in the killing of intracellular pathogens
[14], however its role in mycobacterial pathogenesis has
never been described. In our earlier study, we have shown
that macrophages infected with Rv show decreased expres-
sion of PKC-α as compared to macrophages infected with
MS, suggesting that difference in the intracellular survival
of pathogenic and non-pathogenic mycobacteria may be
related to their ability to downregulate PKC-α [18]. In
present study, to understand the role of PKC-α in survival
or killing of mycobacteria within macrophages, we selec-
tively knocked-down PKC-α of macrophages and exam-
ined their ability to kill intracellular bacilli. We are first to
report the (1) decrease in phagocytosis of mycobacteria by
PKC-α deficient macrophages (2) knockdown of PKC-α
results in increased survival of mycobacteria within mac-
rophages (3) PknG from Mtb selectively downregulates
PKC-α during infection (4) Expression of PknG in MS
reduces the phagocytosis by macrophages and (5) the
downregulation of PKC-α is mainly due to the proteolytic
degradation by PknG.
Results
Downregulation of macrophage specific PKC-α by 
mycobacteria
Previous studies suggest that Rv, Ra and BCG are less effi-
ciently taken up by macrophages as compared to MS [19]
and have the ability to survive and multiply within mac-
rophages. Infection of Rv but not MS inhibits macrophage
PKC-α. The novel (PKC-δ and PKC-θ) and conventional
(PKC-ζ) isoforms are not down regulated by Rv infection
of macrophages [18]. To know whether infection of mac-
rophages with BCG and Ra also results in the downregu-
lation of PKC-α, we infected macrophages with
mycobacteria and observed that infection of THP-1 cells
with BCG and Ra also decreased the expression (2.5 and
5.7 fold respectively) as well as the phosphorylation of
PKC-α by 2.5 and 5 fold respectively (Fig. 1A and 1B).
Regulation PKC-δ was similar by MS, BCG, Ra and Rv (Fig.
1C) suggesting that pathogenic mycobacteria selectively
downregulate PKC-α. The downregulation of PKC-α was
also evident in primary mouse peritoneal macrophages
when incubated with Rv (Fig. 1D and 1E).
Decreased phagocytosis and increased survival of BCG and 
MS within PKC-α deficient THP-1 cells
Our initial study has proven that regulation of macro-
phage PKC-α by mycobacteria is species dependent [18].
To study the effect of PKC-α knockdown on the survival/
killing of mycobacteria, THP-1 cells were transfected with
SiRNA targeting PKC-α. SiRNA specifically reduced the
expression of PKC-α by 70-90% (Fig. 2A). Infection of
PKC-α deficient cells resulted in the significant (p <
0.005) reduction in phagocytosis of BCG. Data show that
phagocytosis of BCG by PKC-α deficient cells was 2.8 fold
reduced when compared to control (Fig. 2B). Intracellular
survival of BCG was found to be increased in PKC-α defi-
cient cells. Since phagocytosis of bacilli by normal and by
PKC-α deficient cells was different, we presented the sur-
vival of BCG as fold increase in the number of intracellu-
lar bacilli as compared to the initial phagocytosis (Fig.
2C). The specificity of PKC-α SiRNA was confirmed by
transfecting mouse macrophage cell line, J774A.1 and
showing that SiRNA blocked PKC-α, only in THP-1 cells
(data not shown).
To clearly understand the specific role of PKC-α in the
phagocytosis and survival of mycobacteria, we used MS
(which does not downregulate PKC-α) for infection.BMC Microbiology 2009, 9:271 http://www.biomedcentral.com/1471-2180/9/271
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Knockdown of PKC-α resulted in the significant (p <
0.0001) decrease in the phagocytosis of MS by macro-
phages (Fig. 3A). Results show that phagocytosis of MS is
2.6 fold less in PKC-α deficient cells as compared to nor-
mal cells. Inhibition of phagocytosis was specific to the
inhibition of PKC-α as knockdown of PKC-δ did not
inhibit the phagocytosis or survival (Fig. 3A, 3B and 3C).
When survival of MS in macrophages deficient in PKC-α
was compared with normal cells, we found that survival of
MS was increased in the PKC-α deficient macrophages.
Since phagocytosis of MS by normal and PKC-α deficient
cells was different, we expressed intracellular survival of
MS as percentage of the initial bacilli uptake. In normal
macrophages, only 25% of initial bacilli survived as con-
trast to 65% survival in PKC-α deficient cells (Fig. 3B). The
results were confirmed with J774A.1 cells using Go6976
(inhibitor of PKC-α) which represented similar level of
inhibition in phagocytosis (Fig. 3D).
Detection of expression of PknG in different mycobacteria
PknG has been shown to inhibit phagosomal maturation
[9], a process that is promoted by PKC-α [13,15-17], and
which helps in survival of mycobacteria within macro-
phages. There seems to be an inverse relationship between
Downregulation of PKC-α expression by mycobacteria Figure 1
Downregulation of PKC-α expression by mycobacteria. THP-1 cells were incubated for 4 h in the presence of myco-
bacteria (MOI = 1:20) as indicated (C, uninfetced). The cells were lysed, and equal amounts of total cell lysates (20 μg) were 
resolved by SDS-PAGE and immunoblotted with an antibody against (A) PKC-α and phosphorylated form of PKC-α (Thr638), 
(B) Densitometric analysis of PKC-α and pPKC-α blots shown in fig. 1A, (C) PKC-δ and phospho-PKCδ (Thr505). The lower 
parts of the blots were probed with an anti-tubulin antibody, to assure equal protein loading (lower panel), (D) and (E) level of 
PKC-α and PKC-δ in mouse peritoneal macrophages. Each experiment was repeated at least 3 times.BMC Microbiology 2009, 9:271 http://www.biomedcentral.com/1471-2180/9/271
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PknG and PKC-α in terms of regulation of events involved
in phagosomal maturation and intracellular survival of
mycobacteria. This led us to think about some relation-
ship between PknG and PKC-α in determining the intrac-
ellular survival of mycobacteria. To check the expression
of PknG in mycobacteria, we cloned, expressed, purified
protein [see additional file 1] and raised antiserum.
Immunoblotting of mycobacterial lysates using anti-
PknG serum shows that PknG is expressed in Rv, Ra and
BCG but not in MS [see additional file 1(C)].
Construction of recombinant MS expressing PknG
To underline the specific role of PknG in controlling PKC-
α, the gene was expressed in MS. Cloning of pknG  in
pMV361 vector was confirmed by restriction digestion
[see additional file 1(D)]. For expression, pMV361-pknG
was electroporated into MS and resultant clones (MS-G)
were confirmed by PCR [see additional file 1(E)] and
immunoblotting using anti-PknG serum [see additional
file 1(F)].
Recombinant MS downregulates macrophage PKC-α 
during infection
BCG and Ra are laboratory produced avirulent strains that
still infect and grow within mammalian hosts, though
they do not lead to the chronic disease that their virulent
counterparts do. However, BCG and Ra are able to inhibit
the maturation of phagosome which is consistent with
their ability to downregulate PKC-α. PknG is expressed by
Rv, BCG, and Ra (bacilli are able to downregulate PKC-α)
but PknG is not expressed in MS (does not downregulate
PKC-α). This led us to speculate that PknG might contrib-
ute to the downregulation of PKC-α by mycobacteria and
resulting in the increased intracellular survival. To test this
hypothesis, we infected THP-1 cells with MS-G and stud-
ied the level of macrophage PKC-α. We found that THP-1
cells infected with MS-G show 2.2 and 2.5 fold decreased
level of PKC-α when compared to control cells and cells
infected with MS respectively (Fig. 4A and 4B). In the
same experiment, expression of pknG mRNA in Rv was
found to be increased by 32 fold (Fig. 4C). Similar results
were observed with J774A.1 cells. Immunoprecipitation
(Fig. 4E, 4G) as well as western blot analyses (Fig. 4D, 4F)
of lysates from J774A.1 cells infected with mycobacteria
confirmed downregulation of PKC-α by MS-G.
Expression of PknG in MS mimics the effect of PKC-α 
knockdown
PknG down regulates PKC-α, resulting in the inhibition of
phagocytosis and increased survival of mycobacteria
Phagocytosis and survival of BCG in PKC-α deficient THP-1 cells Figure 2
Phagocytosis and survival of BCG in PKC-α deficient THP-1 cells. THP-1 cells were incubated in the presence of 30 
nM PMA for 24 h. Then cells were transfected with 20 nM SiRNA and level of PKC-α were determined by immunoblotting. (A) 
24 h after transfection, level of PKC-α and PKC-δ in cells transfected with SiRNA targeting PKC-α or scrambled SiRNA, (B) 24 
h after transfection, (ΔA) cells transfected with SiRNA targeting PKC-α and (S) cells transfected with scrambled SiRNA and 
control cells (C) were infected with BCG (MOI = 1:10) for 2 h, washed and remaining extracellular bacilli were killed by ami-
kacin treatment for 1 h and lysed in 0.05% SDS and plated. Colony forming units (cfu) were determined after 4 week of incuba-
tion. Tukey (T) test was performed for statistical analysis of data (C) Survival of BCG in THP-1 cells transfected with either 
SiRNA targeting PKC-α (ΔA) or scrambled SiRNA (S) after 24 and 48 h, since phagocytosis of BCG in control and PKC-α defi-
cient cells was different, CFU at 0 h was considered 1 and survival of BCG is presented as fold increase in the number of cfu as 
compared to the initial phagocytosis. Data are means ± standard deviations from three independent experiments each per-
formed in 4 replicates. (** = p < 0.005).BMC Microbiology 2009, 9:271 http://www.biomedcentral.com/1471-2180/9/271
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within macrophages. This raised the possibility of
impaired phagocytosis of MS-G in comparison to MS. To
test this we infected THP-1 cells with MS and MS-G and
compared the phagocytosis. We observed significantly
reduced (5 fold less) phagocytosis of MS-G (p < 0.0001),
which was comparable with the phagocytosis of MS by
PKC-α deficient THP-1 cells (Fig. 5A). When phagocytosis
of MS-G by normal and by PKC-α deficient macrophages
was compared, 4 fold decrease (p < 0.0001) in phagocyto-
sis of MS-G by PKC-α deficient cells was observed (Fig.
5A). In the same experiment, we also compared the sur-
vival of MS-G and MS in normal and in PKC-α deficient
macrophages. We observed that survival of MS-G in nor-
mal macrophages was higher than MS but in PKC-α defi-
cient macrophages, MS and MS-G survived equally which
was higher than the survival of MS in normal macro-
phages (Fig. 5B). Western blotting of samples at each time
point confirmed the knockdown of PKC-α throughout the
experiment (Fig. 5C).
Direct inhibition of PKC-α by PknG
PknG expressing mycobacteria are able to downregulate
the expression of PKC-α. Whether downregulation of
PKC-α require mere presence of PknG during infection or
PknG regulate some cellular process which results in
downregulation PKC-α. Cellular process/target which is
responsible for downregulation of PKC-α may be of
mycobacterial or host origin. To explore whether PknG
alone or with mycobacteria is required for the downregu-
lation of PKC-α, pknG was cloned in pIRES2-EGFP vector
(Fig. 6A) and pIRES2-EGFP-pknG  was transfected into
THP-1 cells. Expression of PknG in transfected cells was
confirmed by western blotting (Fig. 6B). Expression of
PknG in THP-1 cells resulted in the decreased level of
PKC-α (Fig. 6C) suggesting that mere expression of PknG
in macrophages without mycobacteria downregulates
PKC-α. This also suggest that downregulation of PKC-α
involves modulation of some host process. In order to dis-
sect, whether this effect of PknG is a direct interaction or
pathway mediated, we performed kinase activity of PknG.
PknG undergoes autophosphorylation (Fig. 6D, lane 1, 92
kDa band) and phosphorylates it's self cleavage product
(Fig. 6D, lane 1, 32 kDa band) but does not phosphor-
ylate PKC-α (Fig. 6D, lane 2) or histone (Fig. 6D, lane 4).
PKC-α phosphorylates histones (Fig. 6D, lane 3, 25 kDa
band) which confirms that PKC-α u s e d  i n  a s s a y  w a s
active. To test if there is any possibility that PknG dephos-
phorylates PKC-α, the immunoprecipitated PKC-α (con-
tain adequate amount of phosphorylated form PKC-α
too) was treated with purified PknG. To our surprise, lev-
els of PKC-α and phosphorylated PKC-α were reduced
upon treatment with PknG suggesting degradation of
Phagocytosis and survival of MS in PKC-α deficient THP-1 cells Figure 3
Phagocytosis and survival of MS in PKC-α deficient THP-1 cells. THP-1 cells were incubated in the presence of 30 nM 
PMA for 24 h. Then cells were transfected with 20 nM SiRNA and after 24 h level of PKC were determined by immunoblotting. 
(A) 24 h after transfection control cells (C) and (ΔA) cells transfected with SiRNA PKCα, (ΔD) cells transfected with SiRNA 
PKCδ, (S) cells transfected with scrambled SiRNA (PKC-α SiRNA which does not block PKCα), were infected with MS (MOI 
= 1:10) for 2 h, washed and remaining extracellular bacilli were killed by amikacin treatment for 1 h, again washed, lysed in 
0.05% SDS and plated for cfu. 'T' test was performed for statistical analysis of data, (B) 24 h after infection % survival of MS in 
THP-1 cells transfected with either SiRNA targeting PKC-α (ΔA) or scrambled SiRNA (S), because phagocytosis of MS was dif-
ferent in control and PKC-α deficient cells, cfu at 0 h was considered 100% and survival of MS is presented as percentage of the 
initial cfu that survive in macrophages after 24 h. (C) 24 h after transfection, level of PKC-δ in cells transfected with SiRNA tar-
geting PKC-δ or scrambled SiRNA, (D) Phagocytosis of MS by mouse macrophage cell line J774A.1 cells pretreated with an 
inhibitor of PKC-α (Go6976) for 30 minute before infection. Data are means ± standard deviations from three independent 
experiments each performed in 4 replicates. (*** = p < 0.0001, * = p < 0.05).BMC Microbiology 2009, 9:271 http://www.biomedcentral.com/1471-2180/9/271
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Downregulation of expression of macrophage PKC-α by recombinant mycobacteria expressing PknG Figure 4
Downregulation of expression of macrophage PKC-α by recombinant mycobacteria expressing PknG. (A) The 
THP-1 cells infected with either wild type or recombinant mycobacteria were lysed, and equal amounts of total cell lysates (20 
μg) were resolved by SDS-PAGE and immunoblotted with an antibody against PKCα. The lower parts of the blots were 
probed with an anti-tubulin antibody, to assure equal protein loading, (B) Densitometric analysis of blots shown in fig. 5A, (C) 
THP-1 cells infected with Rv were osmotically lysed and bacteria were recovered by centrifugation and total bacterial RNA 
was isolated. Total RNA was also isolated from bacterial suspension in RPMI-1640 medium which was used for infection of 
THP-1 cells. RNA samples were treated with DNAse I and cDNA were prepared using random hexamer primers and was 
used as template for Cyber Green real time PCR using pknG specific primers (values presented are normalized against 16S 
rRNA), Data are means ± standard deviations from five independent experiments each performed in 3 replicates. (** = p < 
0.005). (D) experiment identical to 5A was performed with J774A.1 cells, (E) equal amounts of total cell lysates of J774A.1 cells 
infected with mycobacteria were immunoprecipitated with anti-PKC-α antibody and level of PKC-α was analyzed by immuno-
blotting. Same amounts of lysates were also immunoprecipitated with anti-tubulin antibody to serve as control, (F) Densito-
metric analysis of blots shown in fig. 5D, (G) Densitometric analysis of blots shown in fig.5E. The experiments were repeated at 
least 3 times.BMC Microbiology 2009, 9:271 http://www.biomedcentral.com/1471-2180/9/271
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PKC-α (Fig. 6E). This also suggests that the observed
reduced level of phosphorylated form in earlier experi-
ments was due to decrease in total PKC-α protein. How-
ever, PknG treatment did not affected PKC-δ (which is
used as control in the experiment) confirming the specifi-
city of PknG for PKC-α rather than general protease activ-
ity (Fig. 6E). For better understanding of the direct effect
of PknG on PKCα, we incubated macrophage lysate with
purified PknG and observed degradation of PKC-α (Fig.
6F). To further look for the degradation of PKC-α in a time
dependent manner, we treated purified PKC-α with PknG.
The immunoblotting with PKC-α antibody showed that
PknG cleaves PKC-α proteolytically and the resulting
product was detectable with anti-PKC-α antibody (Fig.
6G).
Discussion
The induction of various macrophage functional
responses such as the oxidative burst, MHC class II protein
expression, interleukin 1-β production, tumoricidal activ-
ity, and phagocytosis are thought to be regulated at least
in part via PKC dependent signaling [10]. PKC regulates
IgG mediated phagocytosis by human macrophages and
is reported to translocate to the membrane before signifi-
cant ingestion takes place. PKC inhibitors decreased
phagocytosis in a dose dependent manner. Phagosomal
localization of PKC also increases during phagocytosis
[12]. PKC-α promote Fc-γ receptor mediated phagocytosis
and signal transduction and inhibition of PKC-α results in
inhibition of phagocytosis [20]. During phagocytosis,
MARCKS, PKC-α and Myosin 1 are recruited along with F-
actin and talin in the cortical cytoplasm adjacent to form-
ing phagocytic cups. After completion of particle inges-
tion, myosin I, F-actin, and talin dissociate from
phagosomes. By contrast, MARCKS and PKC-α remain
associated with the phagosome membrane until after
acquisition of the lysosomal marker LAMP-1. Phagocyto-
sis results in rapid and sustained phosphorylation of
MARCKS, suggesting PKC-α dependent phosphorylation
is an early signal required for zymosan phagocytosis and
that MARCKS and PKC-α have roles in phagosome matu-
ration [16]. PKC-α has also been shown to promote
phagosomal maturation by regulating the association of
LAMP-1 and flottilin-1 on phagosomal membrane and
inhibition of PKC-α results in the impairment of phago-
somal maturation [15]. When tubercular and non-tuber-
cular bacilli interact with macrophages, PKC isoforms are
regulated in different manner. We were first to report that
Rv and MS activate and phosphorylate novel PKC iso-
forms. PKC-α (a conventional isoform) was downregu-
lated by Rv but not by MS [18]. It was reported that
macrophages derived from BCG resistant and BCG sensi-
tive mice differ in their PKC activity and that macrophages
from BCG resistant mice show increased PKC activity as
compared to macrophages from BCG sensitive mice [21].
In present study our main objective has been to decipher
the role of PKC-α in mycobacterial survival/killing.
Knockdown of PKC-α resulted in the decreased phagocy-
tosis of BCG and MS by macrophages while their intracel-
lular survival was increased (Fig. 2B, 2C, 3A, 3B).
Inhibition of PKC-δ did not affect phagocytosis or survival
of MS (Fig. 3A and 3C). These data show important role
of PKC-α in phagocytosis as well as in killing of mycobac-
teria and suggest that downregulation of PKC-α during
infection is a strategy utilized by pathogenic mycobacteria
which help them to avoid the lysosomal machinery and
survive inside host cells. This idea is further supported by
the observation that BCG, Ra, and Rv (bacilli can multiply
within macrophages) can downregulate PKC-α while MS
does not (Fig. 1A and 1B). Previous studies with other
organisms have also emphasized the role of PKC-α in
phagocytosis and killing of pathogens. Encapsulated
Streptococcus suis can survive and multiply inside macro-
phages while non-encapsulated S. suis does not. Infection
of J774A.1 macrophages with the non-encapsulated
mutant of S. suis results in the enhanced activation of
PKC-α, whereas the encapsulated strain showed reduced
activation of PKC-α resulting in the reduced phagocytosis
of bacteria [22]. Inhibition of PKC-α by Leishmania dono-
vani lipophosphoglycan results in the decreased phagocy-
tosis by murine macrophages as well as impaired
recruitment of LAMP-1 on the phagosomal membrane
resulting in the arrest of phagosomal maturation [13,23].
Survival of L. donovani promastigotes also involves inhibi-
tion of PKC-α. Intracellular survival of a L. donovani
mutant defective in lipophosphoglycan repeating units
synthesis, which normally is rapidly degraded in
phagolysosomes, was enhanced in DN PKC-α-over-
expressing RAW 264.7 cells [13-15,23]. Interestingly, a
recent study has identified two Mtb strains (i.e. HN885
and HN1554) among a bank of clinical isolates showing
defect in phagocytosis when compared to strain Erdman.
Despite reduced phagocytosis, ingested bacilli replicated
at a faster rate than strain Erdman [24]. These observa-
tions suggest that clinical spectrum of pathogenic myco-
bacteria also include strains capable of avoiding
phagocytosis. Saprophytic and opportunistic pathogenic
mycobacteria are more readily ingested than are the mem-
bers of the Mtb family [19]. Inhibition of PKC-α by BCG,
RA and Rv but not by MS (Fig. 1A and 1B) suggests that
difference in the uptake and intracellular survival of path-
ogenic and non-pathogenic mycobacteria is related at
least in part, to their ability to downregulate PKC-α. Inter-
estingly, mammalian PKC-α has similarity with mycobac-
terial PknG [25]. PknG has been shown to promote
intracellular survival of mycobacteria by inhibiting the
process of phagosomal maturation. PknG is secreted into
the cytosol of infected macrophage suggesting the possi-
bility that it may access host cell molecules. There is
impaired recruitment of LAMP-1 on phagosomes contain-BMC Microbiology 2009, 9:271 http://www.biomedcentral.com/1471-2180/9/271
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ing live mycobacteria expressing PknG [9]. Phagosomes
containing live pathogenic mycobacteria actively retain
Coronin 1, which is generally released prior to fusion with
lysosome [26]. In a further study, Coronin 1 was shown to
be required for activation of Ca2+ dependent phosphatase
calcineurin, thereby blocking the lysososmal delivery of
mycobacteria [27]. PKC-α has been shown to phosphor-
ylate p57 (human homologue of coronin family actin-
binding protein) and PKC mediated phosphorylation of
p57 is required for its dissociation from phagosomes as
well as for recruitment of LAMP-1 to the phagosomes, an
event necessary for the fusion of phagosomes with lyso-
somes [17]. PknG is expressed in BCG, Ra and Rv but not
in MS [see additional file 1(C)] as referred earlier too [28],
led us to speculate that PknG enhances survival of myco-
bacteria by inhibiting PKC-α. When macrophages were
infected with MS-G, expression of PKC-α was decreased as
compared to uninfected and MS infected macrophages
Comparison of phagocytosis and intracellular survival of MS and MS-G in normal and in PKC-α deficient THP-1 cells Figure 5
Comparison of phagocytosis and intracellular survival of MS and MS-G in normal and in PKC-α deficient THP-
1 cells. (A) THP-1 cells were incubated in the presence of 30 nM PMA for 24 h. Cells were then transfected either with SiRNA 
targeting PKC-α (ΔA) or scrambled SiRNA (S) and after 24 h were infected with MS or MS-G (MOI = 1:10) for 2 h, washed and 
remaining extracellular bacilli were killed by amikacin treatment for 1 h, again washed and internalized bacteria were released 
by lysis of macrophages with 0.05% SDS and plated then cfu were counted, (S/MS) phagocytosis of MS by normal THP-1 cells, 
(ΔA/MS) phagocytosis of MS by PKC-α deficient THP-1 cells, (S/MS-G) phagocytosis of MS-G by normal THP-1 cells, (ΔA/MS-
G) phagocytosis of MS-G by PKC-α deficient THP-1 cells. 'T' test was performed for statistical analysis of data. (B) % survival of 
MS and MS-G in normal and PKC-α deficient THP-1 cells. Because, phagocytosis of MS and MS-G were different in control and 
in PKC-α deficient cells, cfu at 0 h was considered 100% and survival of MS is presented as percentage of the initial cfu. (C) At 
each time point of experiment, level of PKC-α in cells transfected either with SiRNA targeting PKC-α or scrambled SiRNA was 
also determined by immunoblotting, to confirm the levels of PKC-α throughout the experiment. Data are means ± standard 
deviations from three independent experiments each performed in 4 replicates. (*** = p < 0.0001).BMC Microbiology 2009, 9:271 http://www.biomedcentral.com/1471-2180/9/271
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Mechanism of downregulation of PKC-α by PknG Figure 6
Mechanism of downregulation of PKC-α by PknG. (A) Cloning of pknG in pIRES2-EGFP vector; M, DNA ladder; 1, 
pIRES2-EGFP-pknG undigested; 2, pIRES2-EGFP undigested; 3, pIRES2-EGFP digested with BamHI; 4, pIRES2-EGFP-pknG 
digested with HindIII; 5, pIRES2-EGFP-pknG digested with BamHI, right oriented recombinants will produce 1.6 kb fragment; (B) 
and (C) pIRES2-EGFP-pknG was transfected in THP-1 cells and after 48 h cells were lysed and immunoblotted with anti-serum 
against PknG and with PKC-α antibodies, lane 1 macrophages transfected with vector alone and lane 2 transfected with 
pIRES2-EGFP-pknG. (D) 5 μg PknG was incubated with immunoprecipitated PKC-α in kinase buffer for 30 min in presence of 
[γ32P]-ATP then resolved by 8% SDS-PAGE and exposed to X-Ray film., lane 1 PknG alone; lane 2 PKC-α and PknG, lane 3 
PKC-α and Histone-4 and lane 4 PknG and Histone-4. (E) THP-1 cell lysate was immunoprecipitated with either antibodies 
against PKC-α or PKC-δ using protein G Sepharose. The immunoprecipitated proteins were incubated with 5 μg purified PknG 
for 1 h and immunoblotted with PKC-α and PKC-δ antibodies. (F) Macrophage cell lysate (50 μg) was incubated with 5 μg puri-
fied PknG or buffer alone for indicated times and immunoblotted with PKC-α antibodies. (G) THP-1 cell lysate was immuno-
precipitated with antibodies against PKC-α and immunoprecipitates were treated with 5 μg of purified PknG for the time 
points as indicated and then immunoblotted with PKC-α antibody. The experiments were repeated at least 3 times.BMC Microbiology 2009, 9:271 http://www.biomedcentral.com/1471-2180/9/271
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(Fig. 4A, 4B, 4D, 4E, 4F and 4G) confirming that PknG
directs the downregulation of PKC-α by mycobacteria
which supports our hypothesis that PknG mediated
enhanced intracellular survival of mycobacteria involves
inhibition of PKC-α. During Rv infection, the levels of
pknG transcripts were increased by 32 fold as compared to
extracellular mycobacteria (Fig. 4C) which reiterates their
ability to affect mycobacterial survival. In normal macro-
phages phagocytosis of MS-G was reduced in comparison
to MS, which was similar with the reduced phagocytosis of
MS by PKC-α deficient macrophages as compared to nor-
mal macrophages (Fig. 5A). Phagocytosis of MS-G was
further reduced in PKC-α deficient macrophages (Fig. 5A)
suggesting that, once MS starts expressing PknG the
behavior of MS-G, in terms of phagocytosis look similar
in pattern with BCG (Fig. 6A). Moreover, survival of MS-
G in normal macrophages mimics the survival of MS in
PKC-α deficient macrophages which was higher than the
survival of MS in normal macrophages (Fig. 5B). MS-G
survives equally in normal and in PKC-α deficient macro-
phages (Fig. 5B). These observations further support the
view that intracellular survival of mycobacteria involves
the inhibition of PKC-α by mycobacterial PknG. Expres-
sion of PKC-α was decreased in macrophages expressing
PknG (Fig. 6B and 6C) confirming that PknG mediated
inhibition of PKC-α involves alteration with host cell
pathway rather than mycobacterial pathway. PknG may
modulate the host cell processes by phosphorylation of
host cell molecule. In a study, level of PKC-α was shown
to be decreased by phosphorylation/dephosphorylation
resulting in the degradation of PKC-α suggesting that
phosphorylation/dephosphorylation is also linked with
the degradation of PKC-α [29]. Thus PknG may contrib-
ute to the downregulation of PKC-α by directly phospho-
rylating it. PknG neither phosphorylated (Fig. 6D) nor
dephosphorylated PKC-α (Fig. 6E) neglecting the possi-
bility of involvement of phosphorylation/dephosphoryla-
tion mediated pathway in downregulation of PKC-α.
Surprisingly, incubation of PKC-α but not PKC-δ with
PknG resulted in the degradation of PKC-α (Fig. 6E).
Besides auto-phosphorylation [30,31], PknG is reported
to catalyse self cleavage [31] which suggests the possibility
of proteolytic degradation of PKC-α by PknG. PKC-δ was
unaffected by PknG confirming the specificity of PknG for
PKC-α. Incubation of macrophage lysate with PknG also
resulted in specific degradation of PKC-α which further
supports that PknG mediated downregulation of PKC-α
may be direct and possibly does not require host or myco-
bacterial mediators (Fig. 6F). When immunoprecipitated
PKC-α was incubated with PknG, PKC-α was specifically
degraded by PknG treatment (Fig. 6G) and this degrada-
tion may be due to the cleavage of PKC-α by PknG treat-
ment as evident by detection of a low molecular weight
protein by anti-PKC-α antibody (Fig. 6G). However, this
cleavage product of PKC-α was not evident in earlier
experiments when macrophages were infected with myco-
bacteria. We speculated that this could be either due to the
lower level/less accumulation of PknG (and degradation
product) in macrophages as compared to exogenous addi-
tion or may be the further degradation of cleaved products
within the cell. Therefore when the proteins were incu-
bated in higher amounts the cleavage product could be
seen. Thus we concluded that the presence of PknG in
macrophages either with mycobacteria or as a protein,
precisely control PKC-α. Moreover, when pathogenic
mycobacteria reside in macrophages it raises the level of
PknG [Fig. 4C] which strengthens the understanding that
more inactivation of PKC-α may be possible. Hence, this
study is first to report that PknG downregulates PKC-α
and their association discriminates the fates of pathogenic
and nonpathogenic mycobacteria in macrophages.
Recently, L. donovani GP63 has been shown to proteolyti-
cally cleave many host proteins resulting in the inactiva-
tion of MAPKs [32] suggesting that cleavage of host
proteins is a defense strategy utilized by intracellular path-
ogens.
During tuberculosis, host defense may be determined, in
part, by the capacity of macrophages to bind and ingest
Mtb. Phagocytosis by macrophages represents the early
step of the mycobacterial infection. It is governed both by
the nature of the host receptors used and the ligands
exposed on the bacteria as well as the environment where
host cells encounter mycobacteria [[24,25], and [33-36]].
Final outcome of the infection is determined by cumula-
tive effect of all these factors.
Conclusions
Expression of PknG in BCG, Ra and Rv but not in MS rep-
resents an interesting example of evolution where patho-
gen has developed strategies for modulation of host
molecule to avoid uptake and killing by the entities
designed for their killing. Interestingly, PknG directs the
downregulation of PKCα and further negotiating the
uptake and survival of mycobacteria. Our data clearly and
for the first time reveal that pathogenic mycobacteria
downregulates PKCα predominantly to avoid phagocyto-
sis and killing by macrophages. Detailed understanding of
the events leading to the downregulation of PKCα by
PknG inside host cells open a new chapter which may fur-
ther project to the identification of new therapeutic targets
for mycobacterial infections.
Methods
Reagents
Antibodies against PKCs and phospho-PKCs were pur-
chased through Santa Cruz Biotech Inc. and Cell Signaling
Technologies, USA, respectively. Horseradish peroxidase-
linked secondary antibodies, polyvinylidene difluoride
membrane, RPMI-1640, DMEM, HEPES, sodium bicarbo-BMC Microbiology 2009, 9:271 http://www.biomedcentral.com/1471-2180/9/271
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nate, Imidazole, IPTG and Protein G Sepharose beads
were purchased from Sigma chemicals. Enhanced chemi-
luminescence kit (ECL) was from GE Healthcare. Middle-
brook 7H9 medium and endotoxin-free fetal calf serum
(FCS) were purchased from Difco laboratories (Sparks,
MD). SiRNAs were procured through Ambion. SiRNA
transfection reagent was purchased from Bio-Rad (USA).
Cell Line Nucleofector Kit V was purchased from Amaxa
Inc. USA.
Cell culture
The THP-1 human macrophage-like cell line was acquired
from the American Type Culture Collection, USA and cul-
tured in RPMI-1640 medium containing 2 mM L-
glutamine, 10 mM HEPES, 1 mM sodium pyruvate, 4.5 g/
L glucose, 1.5 g/L sodium bicarbonate, supplemented
with 10% heat inactivated fetal calf serum and 0.05 mM
β-mercaptoethanol at 37°C, 5% CO2. Cells were treated
with 30 nM PMA for 24 h before using for the experi-
ments. The J774A.1 murine macrophage cell line was
maintained at 37°C, 5% CO2 in DMEM containing 10%
fetal calf serum, 2 mM glutamine and essential amino
acids.
Mycobacteria and macrophage Infection
Mycobacterium tuberculosis H37Rv (Rv), Mycobacterium
tuberculosis H37Ra (Ra), Mycobacterium bovis BCG (BCG)
and Mycobacterium smegmatis MC2 155 (MS) were grown
in Middlebrook (MB) 7H9 medium supplemented with
0.5% glycerol, ADC supplement, 0.5% BSA, fraction V,
0.2% dextrose, 0.85% NaCl and 0.05% Tween 80. Cul-
tures were incubated at 37°C. Mycobacteria grown in
mid-log phase were used for infecting THP-1 cells. The
bacterial suspension was washed and resuspended in
RPMI-1640 containing 10% FCS. Bacterial clumps were
disaggregated by vortexing five times (each cycle~2 min)
with 3-mm sterile glass beads, and then passed through
26 gauge needle 10 times to disaggregate any remaining
clumps. The total number of bacilli per milliliter of sus-
pension was ascertained by measuring OD at 650 nm and
by further counting for cfu on MB7H10 agar plates.
Infection and preparation of cell lysates for western 
blotting
THP-1 cells were seeded at 2 × 106 cells/well in 6 well
plates and were subsequently incubated with 20, myco-
bacteria/macrophage, for 4 h and lysed in phosphoryla-
tion buffer as described previously [18]. Alternatively, 2 ×
106 peritoneal macrophages from BALB/c mouse were
also infected with MS and Rv. Total 20 μg protein sample
was analyzed by 10% SDS-PAGE and electroblotted as
described previously [18]. Briefly, after blocking, the
membranes were incubated overnight at 4°C with anti-
bodies (anti PKC-α and anti PKCδ, 1:1000, anti pPKC-α
and anti pPKCδ, 1:1000, anti tubulin, 1:5000, anti PknG,
1:1000) in 0.1% TBST containing 3% BSA, with gentle
shaking. After four washes with 0.05% TBST, the mem-
brane was incubated with goat anti-rabbit (anti-mouse
when detecting tubulin) polyclonal antibodies conju-
gated to horseradish peroxidase (1:50000) in 0.1%TBST
containing 3% BSA for 1 h at room temperature. After four
washes with 0.05% TBST, the blots were developed using
ECL reagents and were analyzed on Chemi-Doc XRS sys-
tem (Bio-Rad Laboratories, Hercules, CA) using Quantity
One program.
Cloning, expression and purification of PknG
Rv genomic DNA was used as a template for amplification
of  pknG  gene by PCR. The gene was cloned in either
pTriEx4 or in pMV361 vectors using the primers contain-
ing the desired restriction enzyme sites (Table 1). For
expression in E. coli, pknG with HindIII flanking sites was
Table 1: List of PCR primers used in the study.
Primers Genes Description
CCCAAGCTTATGGCCAAAGCGTCAGAGAC pknG Forward with HindIII site, for pTriEx4 vector
CCCAAGCTTTTAGAACGTGCTGGTGGGCC pknG Reverse with HindIII site, for pTriEx4 and pMV361 vector
CCC GAA TTC ATG GCC AAA GCG TCA GAG AC pknG Forward with EcoR1 site, for pMV361 vector
TCAAACGCAGCAAGGGTCAGAAAC pknG Forward, for real time PCR
TCGTTGTAGACCAAGCCGATGGAA pknG Reverse, for real time PCR
TGCAAGTCGAACGGAAAGGTCTCT 16S rRNA Forward, for real time PCR
AGTTTCCCAGGCTTATCCCGAAGT 16S rRNA Reverse, for real time PCRBMC Microbiology 2009, 9:271 http://www.biomedcentral.com/1471-2180/9/271
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subcloned in pTriEx4 vector. For expression in MS, pknG
with  EcoRI/HindIII flanking sites was subcloned into
pMV361 vector. For expression in THP-1 cells, pKnG
cloned in pTriEx4 vector was digested with EcoRI and XhoI
and ligated to pIRES2-EGFP vector predigested with EcoRI
and SalI. Cloning and orientation of gene were confirmed
by PCR and restriction digestion. E. coli BL21 (DE3) cells
were transformed with pTriEX4-pknG and transformants
were grown in LB medium containing ampicillin (100 μg/
ml) at 37°C, till OD at 600 nm reached 0.6. IPTG was
then added to a final concentration of 0.8 mM and cul-
tures were further grown for an additional 4 h at 37°C
with shaking. Cells were harvested by centrifugation at
5000 × g for 15 min and resuspended in binding buffer
[Sodium Phosphate 20 mM (pH 7.4), NaCl 50 mM, Imi-
dazole 5 mM, PMSF 1 mM] and sonicated on ice for 2
min. After sonication TritonX-100 was added in cell lysate
at a final concentration of 1% before centrifugation at
30000 × g for 30 min at 4°C. Supernatant was loaded
onto Ni2+-NTA column, washed with 60 mM Imidazole
and 6-His-PknG was eluted with 200 mM Imidazole.
Affinity purified 6-His-PknG was further purified by size
exclusion chromatography using Sephacryl 200 column
and AKTA Prime protein purification system (GE health-
care).
For expression in MS, cells were transformed with
pMV361-pknG  and grown in MB7H9 medium supple-
mented with Kanamycin (25 μg/ml).
For raising antiserum, purified 6-His-PknG chimeric pro-
tein was injected subcutaneously with Freund's incom-
plete adjuvant. Immunization was performed on days 0, 7
and 21. On day 30 rabbit was bled and the serum was sep-
arated. The antiserum was confirmed for its reactivity with
PknG protein using western blotting and ELISA.
Knockdown of PKC-α
THP-1 cells were seeded at a density of 2 × 106 per well in
6 well tissue culture plate 24 h before transfection. The
medium was replaced at the time of transfection. Cells
were transfected with 20 nM SiRNA using 3 μl transfection
reagent in 1.25 ml medium. After 4 h an additional 1 ml
of fresh medium was added to each well and incubated for
24 h. After transfection viability of monolayers was mon-
itored by the trypan blue dye exclusion method. An aliq-
uot of the cultures were confirmed for the knockdowns of
PKC-α and PKC-δ by western blotting.
Transfection of THP-1 cells with pknG
THP-1 cells were transfected with pIRES2-EGFP-pknG
using Cell Line Nucleofector Kit V as per manufacturer's
protocol. Transfection was confirmed by fluorescent
microscopy as well as by western blotting using anti-PknG
serum.
Assay for phagocytosis and intracellular survival of 
mycobacteria
24 h post transfection cells were washed and infected with
mycobacteria to give a multiplicity of infection (MOI) of
10. Cells were incubated at 37°C and 5% CO2 for 2 h and
then washed 3 times with incomplete medium to remove
most of the extracellular bacteria. Cultures were further
incubated in complete medium supplemented with Ami-
kacin (200 μg/ml) for 1 h at 37°C and 5% CO2. At 0, 16,
24 and 48 h cells were washed 3 times with PBS and lysed
(Before lysis the viability of the monolayer was monitored
by the trypan blue dye exclusion method in all of the
experiments described) with 0.05% SDS solution and
serially diluted in 7H9 medium with 0.05% Tween-80,
and plated onto 7H10 agar plates containing 10% OADC.
Plates were supplemented with Kanamycin (25 μg/ml)
where required. CFU were counted after incubation at
37°C for 4 to 5 days for MS and 3-4 weeks for BCG.
Quantitation of RNA during infection
To isolate RNA from intracellular mycobacteria, macro-
phages were subjected to osmotic lysis and released bacte-
ria were pelleted and total RNA was isolated using Tri-
Reagent (MRL) according to manufacturer's instruction.
Total RNA (4 μg) was digested with RNAse free DNAse
and used for the synthesis of cDNA with random hexamer
primers using Revertaid H Minus First Strand cDNA Syn-
thesis Kit (Fermentas). Quantitative real time PCR was
performed in 96 well plate on Light Cycler 480 system
(Roche) using QuntiTect Cyber green PCR mix (Qiagen)
and results were analyzed using Light Cycler 480 software
(Roche). Primer pairs used for amplification of pknG and
16s rRNA (internal control for pknG) are listed in Table 1.
Immunoprecipitation of PKC
Protein G Sepharose beads were washed twice with PBS
and were incubated with 4 μg of polyclonal anti-PKC anti-
bodies per 100 μl of beads for 1 h at room temperature.
After washing twice with PBS equal amounts (approxi-
mately 1 mg) of total cell lysates were incubated with 200
μl of beads for overnight in cold. After incubation beads
were washed with PBS.
Phosphorylation and dephosphorylation assays for PKC-α 
by PknG
To look if there is any effect on PKC-α by PknG, radioac-
tive kinase assay was performed using [γ32P]-ATP and
PKC-α as substrate as described previously [11,37].BMC Microbiology 2009, 9:271 http://www.biomedcentral.com/1471-2180/9/271
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pTriEx4-pknG undigested, (B) overexpression and purification of PknG; 
1, cells transformed with vector; 2, cells transformed with recombinant; 3, 
cells transformed with vector and induced with IPTG; 4, cells transformed 
with recombinant and induced with IPTG; 5 and 6, purified PknG. (C) 
Immunodetection of PknG in mycobacteria; equal amounts of total cell 
lysates (20 μg) were resolved by SDS-PAGE and immunoblotted with pol-
yclonal antiserum against PknG (1) MS (2) BCG (3) Ra (4) Rv (D) 
Cloning of pknG in pMV361 vector; M, 500 bp DNA ladder; 1, pMV361 
vector uncut; 2, pMV361-pknG uncut; 3, pMV361 digested with EcoRI 
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pMV361-pknG; (F) expression of PknG in MS; equal amounts of total 
cell lysates (20 μg) were resolved by SDS-PAGE and immunoblotted with 
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pknG (3) MS and (4) Rv.
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